Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
07/18/2007 | EP1807450A2 Broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies |
07/18/2007 | EP1807448A2 Nucleophosmin protein (npm) mutants, corresponding gene sequences and uses thereof |
07/18/2007 | EP1807205A1 A method of antibody purification |
07/18/2007 | EP1806970A1 Milk production method |
07/18/2007 | EP1664343A4 Methods and compositions for generation of germline human antibody genes |
07/18/2007 | EP1664120A4 Antibody specifically binding to sulfonylated protein and method for producing the same |
07/18/2007 | EP1539236A4 Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof |
07/18/2007 | EP1098905B1 Rna helicases modulating translation termination |
07/18/2007 | EP0860447B1 Hematopoietic stem cell growth factor (scgf) |
07/18/2007 | EP0842949B1 NOVEL MONOCLONAL ANTIBODY AND METHOD OF IMMUNOLOGICAL ANALYSIS OF e-D DIMER AND e-DD/E COMPLEX |
07/18/2007 | CN1327228C Method of identifying N-terminal proBNP |
07/18/2007 | CN1326997C OMPA gene for outer membrane protein of riemerella anatipestifer and methods of use |
07/18/2007 | CN1326881C Trivalent bispecific antibody and its preparation process and use |
07/18/2007 | CN1326880C G-CSF receptor agonist antibodies and screening method therefor |
07/18/2007 | CN1326879C Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
07/18/2007 | CN1326878C Anti human non-Hodgkin's lymphoma chimeric antibody and its derivative and application |
07/18/2007 | CN1326877C Specific antibody fragments for the human carcinoembryonic antigen (CEA) |
07/18/2007 | CN1326876C Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
07/18/2007 | CN1326874C SARS coronary virus nail protein high-immune-protosegment, coding sequence and its use |
07/18/2007 | CN1326567C Egg yolk antibody composition for preventing and treating atypical pneumonia and its preparation method |
07/18/2007 | CN1326566C Immunotherapeutic combinations for the treatment of tumors |
07/18/2007 | CN1326565C Potentiator for antibody against lymphoid tumor |
07/18/2007 | CN101001880A Method of treating granuloma annulare or sarcoid |
07/18/2007 | CN101001879A Antibodies binding to CD34+/CD36+ fetal but not to adult cells |
07/18/2007 | CN101001878A Interferon alpha receptor 1 antibodies and their uses |
07/18/2007 | CN101001877A Human monoclonal antibodies against human IL-4 |
07/18/2007 | CN101001876A Immunoglobulins comprising predominantly a GlcNacMAN5GLANAC2 glycoform |
07/18/2007 | CN101001875A Immunoglobulins comprising predominantly a man5glcnac2 glycoform |
07/18/2007 | CN101001874A Poly-n-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof |
07/18/2007 | CN101001873A Variant fc regions |
07/18/2007 | CN101001872A Fcgamma-RIIB-specific antibodies and methods of use thereof |
07/18/2007 | CN101001871A Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammation |
07/18/2007 | CN101001645A Il-17 antagonistic antibodies |
07/18/2007 | CN100999737A Trichina paramyosin gene and application thereof |
07/18/2007 | CN100999732A Process of producing anti-humen CD20 monoclone antibody by animal mammary gland |
07/17/2007 | US7244836 Antitumor agents; antiproliferative agents; antiinflammatory agent |
07/17/2007 | US7244835 Nucleotide sequences coding polypeptide for use in the regulation taste |
07/17/2007 | US7244832 host cell tranformed with a nucleic acid encoding an antibody having a composite heavy chain with a variable domain including complementarity determining regions and framework regions comprising human acceptor antibody heavy chain framework region residues |
07/17/2007 | US7244826 May have a cytotoxin, a label, a radionuclide, a drug, a liposome, a ligand, or an antibody effector attached to the antibody |
07/17/2007 | US7244822 Comprises butyrophilin-like proteins for use in identifying modulator for treatment and prevention inflammatory bowel disease |
07/17/2007 | US7244818 Interferon alpha responsive protein |
07/17/2007 | US7244817 Pro1357 polypeptide |
07/17/2007 | US7244615 Producing an antibody comprising complementarity determining regions, heavy and light chains, and non-human donor residues, a variable domain; used for in vivo therapy and diagnosis |
07/17/2007 | US7244613 Expression vector comprising nucleotide sequences coding tubercular complex for use in developing vaccines for treatment and prevention of respiratory system disorders; bactericides |
07/17/2007 | US7244604 HDAC9 polypeptides and polynucleotides and uses thereof |
07/17/2007 | US7244599 Gene and uses therefor to modify pasture qualities of crops |
07/17/2007 | US7244592 Identifying immunoglobulins for use as therapeutic, diagnostic an/or affinity separation agents; in vitro translation |
07/17/2007 | US7244587 Expression vectors encoding bacteriophage signal peptides |
07/17/2007 | US7244580 Immunogenic composition for use in the diagnosis of allergies in mammals |
07/17/2007 | US7244574 reacts with prothrombin forming a complex with phosphatidylserine (PS/PT) but does not react with prothrombin (PT) not forming a complex with phosphatidylserine |
07/17/2007 | US7244429 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
07/17/2007 | US7244428 PRO1357 antibodies |
07/17/2007 | US7244427 Isolated bovine IgG heavy chain protein and its use as an antimicrobial |
07/17/2007 | CA2182013C Humanized antibodies against leukocyte adhesion molecule vla-4 |
07/12/2007 | WO2007079218A2 Metalloproteinase binding proteins |
07/12/2007 | WO2007078202A1 Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (nait) |
07/12/2007 | WO2007077934A1 Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same |
07/12/2007 | WO2007077464A2 Chicken virus vaccine and diagnostic |
07/12/2007 | WO2007077365A2 IMMUNOGLOBULIN G (IgG) CONCENTRATE DEPLETED OF ANTI-A AND ANTI-B ANTIBODIES AND OF POLYREACTIVE IgGs |
07/12/2007 | WO2007077261A1 New method for the treatment of gout or pseudogout |
07/12/2007 | WO2007077173A1 Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them |
07/12/2007 | WO2007077042A1 New method for the treatment of gout or pseudogout |
07/12/2007 | WO2007076950A1 Anti-cd19 antibodies with reduced immunogenicity |
07/12/2007 | WO2007076927A1 Anti-il-6 antibodies preventing the binding of il-6 complexed with il-6ralpha to gp130 |
07/12/2007 | WO2007044616A3 Optimized anti-cd30 antibodies |
07/12/2007 | WO2007039184A3 Method and analytical reagents for identifying therapeutics using biomarkers responsive to thiazolidinediones |
07/12/2007 | WO2007024249A3 Engineering fc antibody regions to confer effector function |
07/12/2007 | WO2007019541A3 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility |
07/12/2007 | WO2007016542A3 Her-2 blocking bifunctional targeted peptides |
07/12/2007 | WO2007007159A3 Anti-madcam antibodies to treat uterine disorders |
07/12/2007 | WO2007005948A3 Methods and compositions for diagnosis and treatment of viral and bacterial infections |
07/12/2007 | WO2007005605A3 Phosphospecific chemokine receptor antibodies |
07/12/2007 | WO2007002261A3 IL-1β BINDING ANTIBODIES AND FRAGMENTS THEREOF |
07/12/2007 | WO2006105343A3 Dkkl-i splice product modulators for cancer diagnosis and therapy |
07/12/2007 | WO2006096653A3 Methods of humanizing immunoglobulin variable regions through rational modification of complementarity determining residues |
07/12/2007 | WO2006096451A3 Methionine sulfoxide antibodies |
07/12/2007 | WO2006039638A3 Treating renal cell carcinoma with an anti-tnf human antibody or fragment |
07/12/2007 | WO2006031928A3 Arf-bp1 as mediator of p53-dependent and independent tumor suppression and uses thereof |
07/12/2007 | WO2005123126A3 Antibodies against human interleukin-13 and uses therefor |
07/12/2007 | WO2005120569A3 Improved therapeutic agent for inos generating illness |
07/12/2007 | WO2005097184A3 Antibodies against nogo receptor |
07/12/2007 | WO2005019409A3 Combinatorial protein library screening by periplasmic expression |
07/12/2007 | WO2003102136A3 Antibodies that specifically bind to neurokinin b |
07/12/2007 | US20070161783 Optimized proteins that target Ep-CAM |
07/12/2007 | US20070161782 Peptides for Detection of Antibody to Ehrlichia ewingii |
07/12/2007 | US20070161604 urinary diseases, central nervous diseases, inflammatory diseases, circulatory diseases, cancer, diabetes, immune system disorders and alimentary diseases |
07/12/2007 | US20070161586 Drug for preventing and treating atherosclerosis |
07/12/2007 | US20070161099 Methods for using polypeptides having amylase activity and nucleic acids encoding them |
07/12/2007 | US20070161089 Method of Producing Pan-Specific Antibodies |
07/12/2007 | US20070161080 Antibodies |
07/12/2007 | US20070161066 Immunoglobulin E detection in mammalian species |
07/12/2007 | US20070161061 Novel composition and methods for the treatment of immune related diseases |
07/12/2007 | US20070161059 N1,n12-diacetylspermine as tumor marker |
07/12/2007 | US20070161050 Monoclonal antibodies to mesenchymal stem cells |
07/12/2007 | US20070161048 Anti nc1 monoclonal antibody |
07/12/2007 | US20070161046 Truncated aggrecanase molecules |
07/12/2007 | US20070161041 Identification of feline or canine probnp |
07/12/2007 | US20070161040 Hybrid proteins of active-site serine beta-lactamase |
07/12/2007 | US20070161021 Novel nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase |
07/12/2007 | US20070160993 Novel centromeric protein shugoshin |